about
Epigenetic Signatures of Cigarette Smoking.Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 womenAdditive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.Testing calibration of risk models at extremes of disease riskA genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.Common germline polymorphisms associated with breast cancer-specific survival.Genetic risk variants associated with in situ breast cancer.Identification of novel genetic markers of breast cancer survival.Association of breast cancer risk loci with breast cancer survival.Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies.Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium.Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study.Weight cycling and the risk of type 2 diabetes in the EPIC-Germany cohort.A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.Association analysis identifies 65 new breast cancer risk loci.Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Body mass index and breast cancer survival: a Mendelian randomization analysis.Tumor-associated auto-antibodies as early detection markers for ovarian cancer? A prospective evaluation.Leveraging family history in population-based case-control association studies.Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesAssociations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
P50
Q30489866-3861800D-FF0A-4FF6-8A7F-30519E857494Q34155371-F41C228F-27BF-4C16-AC96-CB445C8A2AFBQ34472668-1B97CD35-80FC-409B-B6B3-77096EC58ECEQ34678258-6E92E297-51CD-433E-BAED-2F557C9DCAF5Q35093501-E429ADE7-363B-4A72-8720-5B678239A66AQ35794653-105BBD8B-9F28-4891-AC63-C3318E4573ABQ35806601-1CDBD35C-7C79-4DE8-842D-A25E32A0113AQ36014067-3044E3F3-7DDD-4DF2-A769-706AF9B6CEBDQ36191018-683DE95E-28CB-47E3-850F-9210DDD3E5BEQ36383319-B281B30D-52EA-457C-8015-7279D7AB7C55Q36831883-4D796C39-65C5-41E2-9C56-E98DACC5D377Q39734134-C8A528F8-9061-4CFD-A7B1-E2EFA93A948FQ40071035-B4F2F3B9-FBF4-469C-A303-7A39AA655CB5Q40137431-835F025B-9A57-40A9-A5F0-8D8A5991B2B8Q40308621-0CA7C637-C212-4C09-BB13-1EA87F26A658Q40579950-792EF620-FD3C-49FB-A5DA-CCC57697450EQ40917151-CE459A33-EDA7-426D-97C4-F42ADB0947CDQ41351370-705E3816-C5C6-49DF-815D-D722495BED9DQ45305326-8F3A8939-B23E-4CEC-B27C-25C3DD726C17Q45979098-39E8A6B0-BF70-4D4B-9983-E56EF10361CDQ46103372-569F8BE9-1C8E-4D78-942B-9DC2C0690999Q46115524-C945F15A-81BE-4ECF-9B89-F47D67E94146Q50145937-352464D7-6101-4559-AE0C-429CE7C57400Q51124795-B4162777-2617-4F21-B305-8BB00F0DE64AQ52582425-42A6BB9C-DBE5-4B4A-B86C-2314D276F46CQ62583133-C7F39007-D7CA-4E5B-A99B-E99A4ED62175Q62583318-66E6481A-E376-4737-9275-1747A92493C8
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Myrto Barrdahl
@ast
Myrto Barrdahl
@en
Myrto Barrdahl
@es
Myrto Barrdahl
@nl
type
label
Myrto Barrdahl
@ast
Myrto Barrdahl
@en
Myrto Barrdahl
@es
Myrto Barrdahl
@nl
prefLabel
Myrto Barrdahl
@ast
Myrto Barrdahl
@en
Myrto Barrdahl
@es
Myrto Barrdahl
@nl
P106
P31
P496
0000-0003-4661-0763